DK362381A - Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser - Google Patents

Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser

Info

Publication number
DK362381A
DK362381A DK362381A DK362381A DK362381A DK 362381 A DK362381 A DK 362381A DK 362381 A DK362381 A DK 362381A DK 362381 A DK362381 A DK 362381A DK 362381 A DK362381 A DK 362381A
Authority
DK
Denmark
Prior art keywords
polyazaheterocyclic
benefits
preparing
procedure
preparing polyazaheterocyclic
Prior art date
Application number
DK362381A
Other languages
Danish (da)
English (en)
Inventor
J Frei
E Schweizer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK362381A publication Critical patent/DK362381A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK362381A 1980-08-15 1981-08-14 Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser DK362381A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH619780 1980-08-15

Publications (1)

Publication Number Publication Date
DK362381A true DK362381A (da) 1982-02-16

Family

ID=4305798

Family Applications (1)

Application Number Title Priority Date Filing Date
DK362381A DK362381A (da) 1980-08-15 1981-08-14 Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser

Country Status (16)

Country Link
EP (1) EP0046446A1 (cs)
JP (1) JPS5754186A (cs)
KR (1) KR830006293A (cs)
AU (1) AU7409281A (cs)
CA (1) CA1173831A (cs)
DD (1) DD201594A5 (cs)
DK (1) DK362381A (cs)
ES (1) ES504736A0 (cs)
FI (1) FI812518A7 (cs)
GB (1) GB2082577B (cs)
GR (1) GR78233B (cs)
IE (1) IE51498B1 (cs)
IL (1) IL63572A0 (cs)
NO (1) NO812762L (cs)
PT (1) PT73523B (cs)
ZA (1) ZA815621B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188609A (ja) * 1984-03-07 1985-09-26 株式会社スリ−ボンド セルフロッキングねじ部材の製造方法
JPS61167711A (ja) * 1985-01-17 1986-07-29 株式会社 スリ−ボンド セルフロツキング剤及びセルフロツキングねじ部材
DE3730718A1 (de) * 1987-09-12 1989-03-23 Basf Ag Tetracyclische chinazolinderivate, herstellung und verwendung
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds

Also Published As

Publication number Publication date
ZA815621B (en) 1982-08-25
KR830006293A (ko) 1983-09-20
IE51498B1 (en) 1987-01-07
NO812762L (no) 1982-02-16
PT73523A (en) 1981-09-01
GB2082577A (en) 1982-03-10
PT73523B (en) 1983-08-16
IL63572A0 (en) 1981-11-30
AU7409281A (en) 1982-02-18
ES8204992A1 (es) 1982-05-16
DD201594A5 (de) 1983-07-27
FI812518L (fi) 1982-02-16
CA1173831A (en) 1984-09-04
IE811860L (en) 1982-02-15
ES504736A0 (es) 1982-05-16
JPS5754186A (cs) 1982-03-31
GB2082577B (en) 1984-03-28
FI812518A7 (fi) 1982-02-16
GR78233B (cs) 1984-09-26
EP0046446A1 (de) 1982-02-24

Similar Documents

Publication Publication Date Title
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK525481A (da) Fremgangsmaade til fremstilling af pyrimidoner
DK354281A (da) Fremgangsmaade til geninkorporering af kakaoaroma
DK299483D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK489381A (da) Fremgangsmaade til fremstilling af aminopropoxyphenylderivater
DK115581A (da) Fremgangsmaade til fremstilling af pyrimidylquinazoliner
DK501781A (da) Fremgangsmaade til fremstilling af 2-oxoazetidin-derivater
DK372081A (da) Fremgangsmaade til fremstilling af fluorerede pentendiaminderivater
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK283083D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK316981A (da) Fremgangsmaade til fremstilling af pentapeptider
DK231581A (da) Fremgangsmaade til fremstilling af phenoxyaminopropanolderivater
DK142381A (da) Fremgangsmaade til fremstilling af substituerede triarylthiazolforbindelser
DK226881A (da) Fremgangsmaade til fremstilling af 3-picolin
DK369181A (da) Fremgangsmaade til fremstilling af triazolylvinylketonforbindelser
DK371981A (da) Fremgangsmaade til fremstilling af aminoacetonitrilderivater
DK449881A (da) Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783D0 (da) Fremgangsmade til fremstilling af n-phosphonometylglycin
DK60081A (da) Fremgangsmaade til fremstilling af diphenylethercarboxylsyrer
DK380981A (da) Fremgangsmaade til fremstilling af benzoquinoliziner
DK411881A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika
DK57881A (da) Fremgangsmaade til fremstilling af benzylinderivater
DK159417C (da) Fremgangsmaade til fremstilling af alfa-ketocarboxylsyre-n-tert.butylamider

Legal Events

Date Code Title Description
ATS Application withdrawn